Thermo Fisher Scientific Inc. is a prominent player in the healthcare sector, offering a diverse range of solutions in life sciences, diagnostics, and laboratory products. The company has a strong international presence and continues to innovate in the medical and biopharma industries. Its stocks reflect a stable but competitive position in the market.
The fundamental rating of Thermo Fisher Scientific Inc. reflects its solid performance in key financial indicators, albeit with room for improvement in some areas like debt management.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
The historical analysis provides insights into the company's consistent performance across key financial metrics over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-02-04 | 3 | 4 | 4 | 4 | 1 | 2 | 2 |
| n/a | 0 | 4 | 4 | 4 | 1 | 2 | 2 |
Analysts provide price targets which suggest moderate room for growth based on median projections.
| High | Low | Median | Consensus |
|---|---|---|---|
| $750 | $561 | $650 | $643.69 |
The Analyst sentiment reflects a favorable consensus with a majority of 'Buy' recommendations.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 38 | |
| Hold | 4 | |
| Sell | 0 | |
| Strong Sell | 0 |
Thermo Fisher Scientific Inc. presents a robust investment option with strong fundamentals and favorable analyst sentiment. The company's wide range of products and services in critical healthcare and scientific sectors provides a stable growth outlook. However, potential investors must consider the lower scores in debt to equity which indicate financial leverage risks. Overall, TMO remains an attractive long-term investment with promising returns, supported by continued innovation and market presence.